Kiora Pharmaceuticals
KPRX
KPRX
18 hedge funds and large institutions have $3.87M invested in Kiora Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$79.9K | |
| 2 | +$15.1K | |
| 3 | +$7.19K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.95K |
| 5 |
Morgan Stanley
New York
|
+$2.11K |
Top Sellers
| 1 | -$16.7K | |
| 2 | -$6.02K | |
| 3 | -$4.67K | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$1.49K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$972 |
